Stillbirth Clinical Trial
Official title:
Introducing Fetal Scalp Stimulation as an Adjunct to Intermittent Auscultation in Low-Resource Settings.
Verified date | April 2017 |
Source | Duke University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is a pilot study taking place in Moshi, Tanzania at the Kilimanjaro Christian Medical Centre (KCMC). The study aims to introduce fetal scalp stimulation into the intermittent auscultation protocols at KCMC, and to validate whether or not a handheld Doppler device can perform the fetal scalp stimulation test accurately.
Status | Completed |
Enrollment | 550 |
Est. completion date | June 30, 2017 |
Est. primary completion date | June 30, 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 15 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Gestational Age = 37 weeks - Singleton gestation - Cephalic presentation - First stage of labor - Fetal distress diagnosed in the labor ward by either FHR >160 or <110, and/or grade 2-3 meconium-stained liquor Exclusion Criteria: - Chorioamnionitis - Known fetal anomaly - Antepartum hemorrhage - Eclampsia - Other maternal/fetal factors precluding vaginal delivery |
Country | Name | City | State |
---|---|---|---|
Tanzania | Kilimanjaro Christian Medical Center | Moshi | Kilimanjaro |
Lead Sponsor | Collaborator |
---|---|
Duke University | Fulbright, John E. Fogarty International Center (FIC) |
Tanzania,
Clark SL, Gimovsky ML, Miller FC. Fetal heart rate response to scalp blood sampling. Am J Obstet Gynecol. 1982 Nov 15;144(6):706-8. — View Citation
Clark SL, Gimovsky ML, Miller FC. The scalp stimulation test: a clinical alternative to fetal scalp blood sampling. Am J Obstet Gynecol. 1984 Feb 1;148(3):274-7. — View Citation
Omo-Aghoja L. Maternal and fetal Acid-base chemistry: a major determinant of perinatal outcome. Ann Med Health Sci Res. 2014 Jan;4(1):8-17. doi: 10.4103/2141-9248.126602. Review. — View Citation
Rathore AM, Ramji S, Devi CB, Saini S, Manaktala U, Batra S. Fetal scalp stimulation test: an adjunct to intermittent auscultation in non-reassuring fetal status during labor. J Obstet Gynaecol Res. 2011 Jul;37(7):819-24. doi: 10.1111/j.1447-0756.2010.01442.x. Epub 2011 Mar 16. — View Citation
Skupski DW, Rosenberg CR, Eglinton GS. Intrapartum fetal stimulation tests: a meta-analysis. Obstet Gynecol. 2002 Jan;99(1):129-34. — View Citation
Visser GH, Ayres-de-Campos D; FIGO Intrapartum Fetal Monitoring Expert Consensus Panel. FIGO consensus guidelines on intrapartum fetal monitoring: Adjunctive technologies. Int J Gynaecol Obstet. 2015 Oct;131(1):25-9. doi: 10.1016/j.ijgo.2015.06.021. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Birth asphyxia/stillbirth rate | Day 1 | ||
Other | NICU Admission Rate | Day 1 | ||
Primary | Feasibility as measured by completion of all 3 study objectives | Day 1 | ||
Primary | Predicted fetal acidosis from cord blood pH (at thresholds of cord blood pH<7.0, 7.1, and 7.2) | The primary outcome is the sensitivity and specificity of the Doppler device to predict fetal acidosis based on the fetal scalp stimulation test. | Day 1 | |
Secondary | Fetal distress rate | The investigators plan to define the fetal distress rate at a large referral center in Tanzania | Day 1 | |
Secondary | Change in cesarean delivery rate | The investigators plan to compare cesarean delivery rates before and after the introduction of fetal scalp stimulation to fetal monitoring protocols. | baseline, post introduction of fetal scalp stimulation (during labour) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03605511 -
TTP and aHUS in Complicated Pregnancies
|
||
Completed |
NCT02379728 -
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
|
N/A | |
Not yet recruiting |
NCT01664546 -
Study of the Best Blastocyst Post Transfer by aCGH
|
N/A | |
Completed |
NCT02218931 -
ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes
|
N/A | |
Recruiting |
NCT03662178 -
Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
|
||
Completed |
NCT03290924 -
Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach
|
N/A | |
Recruiting |
NCT05901688 -
Umbilical Cord Abnormalities in the Prediction of Adverse Pregnancy Outcomes
|
||
Completed |
NCT02339077 -
Group B Streptococcus (GBS) Associated Stillbirths in a High Burden Setting
|
||
Completed |
NCT03112018 -
Strengthening Facility-based Intrapartum/Immediate Newborn Care to Reduce Mortality of Preterm Infants in Migori County, Kenya and Busoga Region, Uganda
|
N/A | |
Completed |
NCT02318420 -
The PartoMa Project: For Improving Monitoring, Action and Triage During Labour
|
N/A | |
Recruiting |
NCT05757167 -
Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics
|
Phase 4 | |
Completed |
NCT02148952 -
BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program
|
N/A | |
Active, not recruiting |
NCT01995968 -
Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.
|
N/A | |
Completed |
NCT00270530 -
Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia
|
Phase 4 | |
Completed |
NCT04600076 -
MOMSonLINE2 ; A Pilot Study Testing Recruitment and Retention of Women of Color to an Online Support Group for Bereaved Mothers
|
N/A | |
Completed |
NCT03363308 -
Effects of a Health Workforce Capacity Building and Quality Improvement Intervention in Kinshasa
|
N/A | |
Completed |
NCT03722615 -
Epidemiology of Congenital Cytomegalovirus in a High HIV Prevalence Setting, South Africa
|
||
Completed |
NCT02907242 -
Revealed Versus Concealed Cerebroplacental Ratio
|
N/A | |
Recruiting |
NCT02336243 -
A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders
|
Phase 3 | |
Completed |
NCT00133744 -
Impact of Prenatal Vitamin/Mineral Supplements on Perinatal Mortality
|
Phase 3 |